PACS Group, Inc. (PACS) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
PACS Group, Inc. stock (PACS) is currently trading at $32.61. PACS Group, Inc. PE ratio is 27.63. PACS Group, Inc. PS ratio (Price-to-Sales) is 1.00. Analyst consensus price target for PACS is $46.40. WallStSmart rates PACS as Hold.
- PACS PE ratio analysis and historical PE chart
- PACS PS ratio (Price-to-Sales) history and trend
- PACS intrinsic value — DCF, Graham Number, EPV models
- PACS stock price prediction 2025 2026 2027 2028 2029 2030
- PACS fair value vs current price
- PACS insider transactions and insider buying
- Is PACS undervalued or overvalued?
- PACS Group, Inc. financial analysis — revenue, earnings, cash flow
- PACS Piotroski F-Score and Altman Z-Score
- PACS analyst price target and Smart Rating
PACS Group, Inc.
📊 No data available
Try selecting a different time range
PACS Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · PACS Group, Inc. (PACS)
PACS trades at a significant discount to its Graham intrinsic value of $57.10, offering a 31% margin of safety — a level value investors typically seek before buying.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
PACS Group, Inc. (PACS) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in peg ratio, return on equity, price/sales. Concerns around operating margin and price/book. Fundamentals are solid but monitor weak areas for improvement.
PACS Group, Inc. (PACS) Key Strengths (5)
Earnings per share surging 57.20% year-over-year
Every $100 of equity generates $23 in profit
Good growth relative to its price
Paying $1.00 for every $1 of annual revenue
Mid-cap company balancing growth potential with stability
Supporting Valuation Data
PACS Group, Inc. (PACS) Areas to Watch (5)
Very thin margins with limited operational efficiency
Very expensive at 5.5x book value
Very thin margins, barely profitable
Low institutional interest, mostly retail-driven
Solid revenue growth at 12.40% per year
Supporting Valuation Data
PACS Group, Inc. (PACS) Detailed Analysis Report
Overall Assessment
This company scores 58/100 in our Smart Analysis, earning a C grade. Out of 10 metrics analyzed, 5 register as strengths (avg 8.4/10) while 5 fall into concern territory (avg 3.2/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on EPS Growth, Return on Equity, PEG Ratio. Valuation metrics including PEG Ratio (1.03), Price/Sales (1.00) suggest the stock is attractively priced. Profitability is solid with Return on Equity at 23.00%. Growth metrics are encouraging with EPS Growth at 57.20%.
The Bear Case
The primary concerns are Operating Margin, Price/Book, Profit Margin. Some valuation metrics including Price/Book (5.55) suggest expensive pricing. Growth concerns include Revenue Growth at 12.40%, which may limit upside. Profitability pressure is visible in Operating Margin at 6.97%, Profit Margin at 3.62%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Operating Margin improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 23.00% currently healthy but needing to be sustained. Third, growth sustainability, with Revenue Growth at 12.40% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a moderate-to-high risk investment. Strengths and concerns are roughly balanced. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Mixed fundamentals with both positives (EPS Growth, Return on Equity) and negatives (Operating Margin, Price/Book). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
PACS Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
PACS's Price-to-Sales ratio of 1.00x sits near its historical average of 1.03x (29th percentile), suggesting the market is pricing in steady-state growth. The current valuation is 6% below its historical high of 1.07x set in Mar 2026, and 1% above its historical low of 0.99x in Mar 2026.
Compare PACS with Competitors
Top MEDICAL CARE FACILITIES stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for PACS Group, Inc. (PACS) · HEALTHCARE › MEDICAL CARE FACILITIES
The Big Picture
PACS Group, Inc. operates as a stable business with moderate growth and solid fundamentals. Revenue reached 5.3B with 12% growth year-over-year. Profit margins are thin at 3.6%, typical for companies in this phase that are reinvesting heavily in growth.
Key Findings
ROE of 23.0% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.
Free cash flow is -16M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
Debt-to-equity ratio of 4.93 is elevated. High leverage amplifies both gains and losses and increases financial risk.
What to Watch Next
Margin expansion: can PACS Group, Inc. push profit margins above 15% as the business scales?
Debt management: total debt of 3.5B is significantly higher than cash (158M). Monitor refinancing risk.
Sector dynamics: monitor MEDICAL CARE FACILITIES industry trends, competitive moves, and regulatory changes that could impact PACS Group, Inc..
Bottom Line
PACS Group, Inc. offers stability with moderate growth and solid fundamentals. The valuation may present an opportunity for patient investors, though limited growth means returns will likely come from dividends and modest capital appreciation rather than explosive gains.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Data sourced from SEC Form 4 filings
Last updated: 10:04:34 AM
About PACS Group, Inc.(PACS)
NYSE
HEALTHCARE
MEDICAL CARE FACILITIES
USA
PACS Group, Inc. is a leading technology solutions provider focused on enhancing operational efficiency and productivity across a wide array of industries. The company excels in developing innovative software and hardware systems that optimize workflows and enhance data management capabilities. With a strong commitment to research and development, PACS Group is well-positioned to capitalize on emerging technological trends, reinforcing its status as a key player in the digital transformation landscape. Its strategic partnerships and extensive market presence further strengthen its competitive advantage, presenting a compelling investment opportunity for institutional investors seeking growth in the evolving technology sector.